NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.

A National Institutes of Health study will evaluate whether to screen tens of thousands of healthy infants for genetic ...

Rapidly Advancing Five IRD Programs​with Four Clinical Data Readouts Expected in 2027RDH12, MERTK and RHO Programs Expected to Enter Clinical ...

A new long-read DNA test improves rare disease diagnosis, replaces multiple existing tests, and could become the preferred ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise MRD™, broadening availability to patients ...

A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research presented to the annual conference of the European Society of Human Genetics.

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 9.2% in the morning session after the ...

Scientists have uncovered a surprising new genetic cause of a rare movement disorder after analyzing nearly 3,000 patients ...

When it came time to start a family, Sarah Elizabeth Orlando, 33, knew she would go about it differently. Before she was born, an in-utero amniocentesis had confirmed she carried the gene for fragile ...

From chromosomal anomalies to subtle molecular marks on sperm, hidden biological factors can silently erode fertility even ...